Clinical trial
A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for…
NCT04903288 · PTC Therapeutics, Industry · Active, not recruiting
Key facts
| NCT number | NCT04903288 |
|---|---|
| Title | A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants |
| Official title | An Open-Label Trial to Address the Safety of the SmartFlow MR-Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Subjects |
| Lead sponsor | PTC Therapeutics, Industry |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | AADC Deficiency |
| Intervention type | Genetic |
| Interventions | Eladocagene Exuparvovec |
| Enrollment | 13 |
| Start date | May 12, 2021 |
| Primary completion | May 22, 2023 |
| Completion | Apr 30, 2028 |
| First posted | May 26, 2021 |
| Last update posted | Jan 30, 2026 |
| Countries | Israel, Taiwan, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: